SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001280600-20-000032
Filing Date
2020-05-05
Accepted
2020-05-05 17:06:47
Documents
18
Period of Report
2020-04-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xlrn-20200430form8xk.htm   iXBRL 8-K 54217
2 EXHIBIT 99.1 xlrn-20200430form8xk991.htm EX-99.1 47211
3 EXHIBIT 99.2 xlrn-20200430form8xk992.htm EX-99.2 18510
9 bms2020a.gif GRAPHIC 5432
10 xlrnlogo_image1.gif GRAPHIC 11516
  Complete submission text file 0001280600-20-000032.txt   303351

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xlrn-20200430.xsd EX-101.SCH 4465
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT xlrn-20200430_cal.xml EX-101.CAL 634
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xlrn-20200430_def.xml EX-101.DEF 1484
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xlrn-20200430_lab.xml EX-101.LAB 26147
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xlrn-20200430_pre.xml EX-101.PRE 13590
15 EXTRACTED XBRL INSTANCE DOCUMENT xlrn-20200430form8xk_htm.xml XML 4526
Mailing Address 128 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 128 SIDNEY STREET CAMBRIDGE MA 02139 617-649-9200
ACCELERON PHARMA INC (Filer) CIK: 0001280600 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36065 | Film No.: 20849881
SIC: 2836 Biological Products, (No Diagnostic Substances)